Nagahama, Japan

Kazuyoshi Hanazawa

This inventor holds 2 USPTO granted patents. Top assignee: Toray Industries, Inc.. Active years: 1987-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuyoshi Hanazawa. Retrieved from https://idiyas.com/inventor/kazuyoshi-hanazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1987-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuyoshi Hanazawa: Innovator in Endotoxin Detoxification

Introduction

Kazuyoshi Hanazawa is a notable inventor based in Nagahama, Japan. He has made significant contributions to the field of endotoxin detoxification, holding 2 patents that focus on innovative materials and methods for removing endotoxins from fluids.

Latest Patents

Hanazawa's latest patents include an endotoxin detoxifying material that comprises a fibrous carrier to which Polymyxin is fixed. This invention also features a method for removing endotoxin from a fluid by contacting it with the detoxifying material. His work enables safe and direct contact of blood with Polymyxin, providing a new therapeutic approach for endotoxemia and its prophylaxis.

Career Highlights

Kazuyoshi Hanazawa is associated with Toray Industries, Inc., where he continues to develop groundbreaking solutions in the field of medical technology. His research has the potential to significantly impact the treatment of endotoxemia, enhancing patient safety and therapeutic outcomes.

Collaborations

Hanazawa has collaborated with notable colleagues such as Masashi Kodama and Toru Tani, contributing to the advancement of research in endotoxin detoxification.

Conclusion

Kazuyoshi Hanazawa's innovative work in endotoxin detoxification exemplifies the importance of research and development in medical technology. His contributions are paving the way for safer therapeutic methods in treating endotoxemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…